Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration
ClinicalTrials.gov study NCT00766337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
ClinicalTrials.gov study NCT02251067. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC
ClinicalTrials.gov study NCT06439771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2
ClinicalTrials.gov study NCT03320889. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-D
ClinicalTrials.gov study NCT06673368. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
ClinicalTrials.gov study NCT06968845. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
ClinicalTrials.gov study NCT00306748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT01718847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve
ClinicalTrials.gov study NCT06491758. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
ClinicalTrials.gov study NCT07053059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML
ClinicalTrials.gov study NCT05199051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
ClinicalTrials.gov study NCT07283731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass
ClinicalTrials.gov study NCT04003467. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
ClinicalTrials.gov study NCT01896583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
ClinicalTrials.gov study NCT06990269. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
ClinicalTrials.gov study NCT05761951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT00558207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors W
ClinicalTrials.gov study NCT07318649. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele
ClinicalTrials.gov study NCT04135495. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
ClinicalTrials.gov study NCT07096843. IPD Sharing: NO. Countries: 7. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.